Healthcare

Shares of Mesoblast Ltd (ASX:MSB) have experienced a pullback in recent trading sessions. The stock has delivered a negative return of 8.63% over the past one year as on 20 January 2026, yet the stock continues to attract attention following Jefferies’ decision to maintain …

PolyNovo Limited (ASX:PNV)was in focus during morning trade on19 January, with its share price rising after the company released unaudited trading results for the first half of FY26. The update outlined revenue growth across major regions, improved operating cash flow, and progress on regulatory …

4DMedical Ltd (ASX:4DX) has delivered one of the most pronounced share price moves on the Australian market over the past six months, with its stock rising 1,712% during the period. The rally followed a sequence of regulatory approvals, reimbursement confirmation and capital raising activity …

Neuren Pharmaceuticals (ASX:NEU) saw its shares trade at AUD 20.75 on 14 January 2026, up 7.51% for the day. The company has recorded a 7.62% increase over the past month, a 44.43% rise in the last six months, and an 11.66% gain year-to-date.

EBR Systems, Inc. (ASX:EBR) is a medical device company focused on the development of the WiSE® CRT System, a leadless and wireless cardiac resynchronization therapy designed for patients with heart rhythm disorders. The system delivers left ventricular endocardial pacing without the use of traditional …

Mesoblast Ltd (ASX:MSB) surged to fresh highs on Friday (9 January 2026), touching its 52-week peak of AUD 3.31 during the trading session after releasing an update that showed a sharp increase in quarterlyrevenuefrom its flagship therapy, Ryoncil®. The biotech company’s share price climbed …

Orthocell Limited (ASX:OCC) has reported record quarterly revenue ofAUD 3.2 millionfor the quarter ended 31 December 2025, marking its seventh consecutive quarter of record revenue. The result was supported by increased sales of the Remplir™ nerve repair product across existing markets and early contributions …